Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – Bundlezy

Nektar Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PressBee – SAN FRANCISCO, Dec. 5, 2025 /PRNewswire/ — Nektar Therapeutics (NASDAQ: NKTR) today announced that the Organization and Compensation Committee of Nektar’s

About admin